Celldex Therapeutics to Present at Cantor Global Healthcare Conference
25 Septiembre 2023 - 7:31AM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that
management will participate in a fireside chat at the Cantor Global
Healthcare Conference on Tuesday, September 26th at 1:00 pm ET. A
webcast of the presentation will be available on the "Events &
Presentations" page of the "Investors & Media" section of the
Celldex website. A replay will be available for 90 days following
the event.
About Celldex Therapeutics,
Inc.Celldex is a clinical stage biotechnology company
dedicated to developing monoclonal and bispecific antibodies that
address devastating diseases for which available treatments are
inadequate. Our pipeline includes antibody-based therapeutics which
have the ability to engage the human immune system and/or directly
affect critical pathways to improve the lives of patients with
inflammatory diseases and many forms of cancer. Visit
www.celldex.com.
Company ContactSarah
CavanaughSenior Vice President, Corporate Affairs &
Administration(508) 864-8337scavanaugh@celldex.com
Patrick TillMeru Advisors(484)
788-8560ptill@meruadvisors.com
Celldex Therapeutics (NASDAQ:CLDX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Celldex Therapeutics (NASDAQ:CLDX)
Gráfica de Acción Histórica
De May 2023 a May 2024